FDA Analysis of Racial Demographics in Multiple Myeloma Trials

被引：0
|
作者：
Bhatnagar, Vishal
Gormley, Nicole
Kazandjian, Dickran
Goldberg, Kirsten
Mckee, Amy E.
Blumenthal, Gideon
Farrell, Ann T.
Pazdur, Richard
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4352
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials
    Kanapuru, Bindu
    Fernandes, Laura L.
    Fashoyin-Aje, Lola A.
    Baines, Andrea C.
    Bhatnagar, Vishal
    Ershler, Rachel
    Gwise, Thomas
    Kluetz, Paul
    Pazdur, Richard
    Pulte, Elizabeth
    Shen, Yuan-Li
    Gormley, Nicole
    [J]. BLOOD ADVANCES, 2022, 6 (06) : 1684 - 1691
  • [2] FDA analysis: Impact of BMI on efficacy outcomes in multiple myeloma trials.
    Ershler, Rachel
    Fernandes, Laura L.
    Kanapuru, Bindu
    Gwise, Thomas
    Kluetz, Paul Gustav
    Theoret, Marc Robert
    Gormley, Nicole
    Pazdur, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] FDA analysis of pembrolizumab trials in multiple myeloma: Immune related adverse events (irAEs) and response.
    Krauss, Aviva C.
    Mulkey, Flora
    Shen, Yuan-Li
    Rosenberg, Amy
    Miller, Barry
    Carioti, Theresa
    Scott, Kimberly
    Gormley, Nicole
    Theoret, Marc Robert
    Sridhara, Rajeshwari
    Farrell, Ann T.
    Pazdur, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Racial disparities among patients with multiple myeloma enrolled in clinical trials
    Nishat, Nabilah
    Bari, Thoasin
    Islam, Shahidul
    Braunstein, Marc Justin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 89 - 89
  • [5] Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis
    Benjamin A. Derman
    Jagoda Jasielec
    Spencer S. Langerman
    Wei Zhang
    Andrzej J. Jakubowiak
    Brian C.-H. Chiu
    [J]. Blood Cancer Journal, 10
  • [6] Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis
    Derman, Benjamin A.
    Jasielec, Jagoda
    Langerman, Spencer S.
    Zhang, Wei
    Jakubowiak, Andrzej J.
    Chiu, Brian C-H
    [J]. BLOOD CANCER JOURNAL, 2020, 10 (08)
  • [7] Age demographics of subjects enrolled in interventional phase 3 multiple myeloma clinical trials
    Borad, Abhilasha
    Saeed, Hamnah
    Toscani, Michael
    Barone, Joseph
    Weber, Paul
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (06) : 1475 - 1481
  • [8] Racial bias in multiple myeloma clinical trials: Racial minorities continue to miss out on treatment advances
    Jasaraj, Ranjit
    Gaire, Suman
    Proskuriakova, Ekaterina
    Jasaraj, Ranjana
    Keruakous, Amany R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trials
    Kanapuru, Bindu
    Fernandes, Laura L.
    Baines, Andrea
    Ershler, Rachel
    Bhatnagar, Vishal
    Pulte, Elizabeth
    Gwise, Thomas
    Theoret, Marc R.
    Pazdur, Richard
    Fashoyin-Aje, Lola
    Gormley, Nicole
    [J]. BLOOD, 2023, 142 (03) : 235 - 243
  • [10] Characterization of Patient-Reported Outcomes in Multiple Myeloma Registrational Trials Submitted to the US FDA
    Fernandes, Laura
    Zhou, Jiaxi
    King-Kallimanis, Bellinda L.
    Gwise, Thomas
    Kluetz, Paul
    Bhatnagar, Vishal
    [J]. BLOOD, 2020, 136
12345